# Sildenafil for Early Pulmonary Vascular Disease in Scleroderma

> **NCT04797286** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 30 (estimated)

## Conditions studied

- Scleroderma
- Mildly Elevated Pulmonary Pressures

## Interventions

- **DRUG:** Sildenafil
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04797286
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-20
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04797286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04797286, "Sildenafil for Early Pulmonary Vascular Disease in Scleroderma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04797286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*